Liraglutide 1.8mg: How Long To Stay On

If you have been taking liraglutide at 1.8mg, you're likely wondering how long to stay on this dose before adjusting. The answer depends on your treatment goals, your body's response, and whether your physician is targeting blood sugar management or weight loss. We will walk through what the clinical data says and how real-world treatment decisions are typically made.

How the 1.8mg Dose in the Liraglutide space

Liraglutide is available in two branded forms. Victoza is approved for type 2 diabetes at doses up to 1.8mg daily. Saxenda is approved for chronic weight management at 3.0mg daily. The 1.8mg dose sits at the top of the Victoza range and in the middle of the Saxenda titration schedule.

This distinction matters because your reason for taking liraglutide directly shapes how long you stay at 1.8mg.

For Type 2 Diabetes: 1.8mg as a Maintenance Dose

If your physician prescribed liraglutide for blood sugar control, 1.8mg is the maximum approved dose under the Victoza label. In the LEAD (Liraglutide Effect and Action in Diabetes) clinical trial program, patients remained at 1.8mg for the full study duration, typically 26 to 52 weeks, and saw sustained improvements in HbA1c.

In clinical practice, many patients stay at 1.8mg indefinitely as long as their blood sugar remains well controlled and they tolerate the medication. There's no preset stopping point. Your physician will reassess at regular intervals, typically every three to six months, using HbA1c levels and fasting glucose readings as guides.

For Weight Management: 1.8mg as a Transitional Dose

If your treatment goal is weight loss, the 1.8mg dose is a stepping stone in the Saxenda titration schedule. The standard escalation goes:

• Week 1: 0.6mg daily
• Week 2: 1.2mg daily
• Week 3: 1.8mg daily
• Week 4: 2.4mg daily
• Week 5 onward: 3.0mg daily (maintenance)

Under this protocol, most patients spend about one week at 1.8mg before moving to 2.4mg. But your physician may extend your time at 1.8mg if you're experiencing significant GI side effects. Some patients stay at 1.8mg for two to four weeks until symptoms settle before continuing the escalation.

There's also a subset of patients who reach meaningful weight loss at 1.8mg and, in consultation with their physician, remain at this dose rather than advancing. While the SCALE trials primarily studied the 3.0mg dose, some patients prefer the lower side-effect burden at 1.8mg, particularly if they're achieving satisfactory results.

What the Research Says About Long-Term Use

The SCALE Maintenance trial followed patients on liraglutide 3.0mg for 56 weeks and found that weight loss was maintained throughout the study period. The LEADER cardiovascular outcomes trial studied liraglutide 1.8mg in patients with type 2 diabetes for a median of 3.8 years and found cardiovascular benefits alongside glycemic control.

This long-term data suggests that liraglutide is safe for extended use, with ongoing monitoring. Weight regain after discontinuation is common with all GLP-1 medications, so stopping should be a careful, planned decision made with your physician.

Signs You May Need to Adjust

Talk to your physician about modifying your dose if:

• Your blood sugar levels are rising despite good adherence and lifestyle habits
• Weight loss has stalled for more than 8 to 12 weeks with no other explanation
• Side effects at 1.8mg remain bothersome after several weeks of use
• You have reached your weight or metabolic goals and want to discuss tapering
• New medications have been added that might interact with liraglutide

Frequently Asked Questions

Can I stay on liraglutide 1.8mg forever?

For type 2 diabetes management, many patients use liraglutide 1.8mg as ongoing maintenance therapy for years. The LEADER trial followed patients for nearly four years with a favorable safety profile. Your physician will periodically assess whether the medication is still the best option for you. liraglutide long-term safety

Will I gain weight if I stop liraglutide 1.8mg?

Weight regain is common after stopping GLP-1 receptor agonists. Studies show that patients tend to regain a significant portion of lost weight within 12 months of discontinuation. If you're considering stopping, work with your physician on a gradual plan that includes sustained lifestyle changes.

How do I know if 1.8mg is enough or if I need to go higher?

Your physician will look at your specific metrics. For diabetes, HbA1c below 7% is a common target. For weight management, a loss of at least 5% of baseline body weight by 12 weeks on the target dose is often used as a benchmark for continued therapy.

Is it safe to take liraglutide 1.8mg with other diabetes medications?

Liraglutide 1.8mg is frequently used alongside metformin, SGLT2 inhibitors, and other diabetes therapies. Combining it with insulin or sulfonylureas increases the risk of hypoglycemia, so dose adjustments may be needed. Always inform your physician of every medication you take. liraglutide drug interactions

What happens during the first few weeks at 1.8mg?

If you have titrated up from a lower dose, side effects at 1.8mg are usually manageable because your body has already begun adapting. Some patients notice a temporary uptick in nausea or fullness that resolves within one to two weeks. If you're starting from scratch (which is unusual), side effects may be more pronounced.

Work With a Physician Who Knows GLP-1 Therapy

At FormBlends, our physicians specialize in GLP-1 medications and build individualized treatment timelines. If you're managing diabetes at 1.8mg or on your way to a higher dose for weight loss, we monitor your progress and adjust your plan based on your results and how you feel.

Ready to get clarity on your liraglutide treatment plan? Schedule a consultation with a FormBlends physician today.